IQ AI Ltd.: IB Neuro's Quantitative Mapping Method Assesses Metastatic Tumors
Study Shows DSC MRI Perfusion Distinguishes Tumor from Non-Tumor TissueMILWAUKEE, WI / ACCESSWIRE / May 3, 2022 / Imaging Biometrics, LLC (IB), a subsidiary of IQ-AI Limited, (OTCQB:IQAIF)(LSE:IQAI), notes